Interferon beta 6 million units per week was administered to a patient with an aggressive astrocytoma in the tectum that was resistant to cisplatin, etoposide, vinblastine, and the oral alkylating agent temozolomide. The tumor was immunopositive for O6-methylguanine-DNA methyltransferase (MGMT). Interferon beta caused the disappearance of the gadolinium-enhanced lesion in the tectum. Interferons have apoptotic and antiangiogenic effects on tumor cells, and the lesion's disappearance may have been induced by complexes of these effects. Administration of interferon beta might have a favorable effect on tectal gliomas that are immunopositive for MGMT and resistant to chemoradiotherapy including temozolomide.
MatsunoA., NagashimaH., IshiiH., IwamuroH., NagashimaT.: Aggressive and invasive growth of tectal glioma after surgical intervention and chemoradiotherapy.Br J Neurosurg, 20: 246–249, 2006.
2.
KleihuesP., LouisD.N., ScheithauerB.W., RorkeL.B., ReifenbergerG., BurgerP.C., CaveneeW.K.: The WHO classification of tumors of the nervous system.J Neuropathol Exp Neurol, 61: 215–225, 2002.
3.
Chawla-SarkarM., LindnerD.J., LiuY.F., WilliamsB.R., SenG.C., SilvermanR.H., BordenE.C.: Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis.Apoptosis, 8: 237–249, 2003.
4.
DerS.D., ZhouA., WilliamsB.R., SilvermanR.H.: Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays.Proc Natl Acad Sci, 95: 15623–15628, 1998.
5.
de VeerM.J., HolkoM., FrevelM., WalkerE., DerS., ParanjapeJ.M., SilvermanR.H., WilliamsB.R.: Functional classification of interferon-stimulated genes identified using microarrays.J Leukoc Biol, 69: 912–920, 2001.
6.
PfefferL.M., DinarelloC.A., HerbermanR.B., WilliamsB.R., BordenE.C., BordensR., WalterM.R., NagabhushanT.L., TrottaP.P., PestkaS.: Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons.Cancer Res, 58: 2489–2499, 1998.
7.
StarkG.R., KerrI.M., WilliamsB.R., SilvermanR.H., SchreiberR.D.: How cells respond to interferons.Annu Rev Biochem, 67: 227–264, 1998.
8.
GarrisonJ.I., BerensM.E., ShapiroJ.R., TreasurywalaS., Floyd-SmithG.: Interferon-beta inhibits proliferation and progression through S phase of the cell cycle in five glioma cell lines.J Neurooncol, 30: 213–223, 1996.
9.
KitoT., KurodaE., YokotaA., YamashitaU.: Enhancement of macrophage cytotoxicity against murine gliomas by interferon beta: increase in nitric oxide production in response to glioma-derived soluble factors.J Neurosurg, 97: 619–626, 2002.
10.
TakanoS., KamiyamaH., TsuboiK., MatsumuraA.: Angiogenesis and antiangiogenic therapy for malignant gliomas.Brain Tumor Pathol, 21: 69–73, 2004.
11.
Chawla-SarkarM., LeamanD.W., BordenE.C.: Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines.Clin Cancer Res, 7: 1821–1831, 2001.
12.
MorrisonB.H., BauerJ.A., KalvakolanuD.V., LindnerD.J.: Inositol hexakisphosphate kinase 2 mediates growth suppressive and apoptotic effects of interferon-beta in ovarian carcinoma cells.J Biol Chem, 276: 24965–24970, 2001.
OtsukiT., YamadaO., SakaguchiH., TomokuniA., WadaH., YawataY., UekiA.: Human myeloma cell apoptosis induced by interferon-alpha.Br J Haematol, 103: 518–529, 1998.
15.
SangfeltO., EricksonS., CastroJ., HeidenT., EinhornS., GranderD.: Induction of apoptosis and inhibition of cell growth are independent responses to interferon-alpha in hematopoietic cell lines.Cell Growth Differ, 8: 343–352, 1997.
16.
ThyrellL., EricksonS., ZhivotovskyB., PokrovskajaK., SangfeltO., CastroJ., EinhornS., GranderD.: Mechanisms of interferon-alpha induced apoptosis in malignant cells.Oncogene, 21: 1251–1262, 2002.
